Corrigendum to "Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib".
Stefania GoriniAntonella De AngelisLiberato BerrinoNatalia MalaraGiuseppe RosanoElisabetta FerraroPublished in: Oxidative medicine and cellular longevity (2019)
[This corrects the article DOI: 10.1155/2018/7582730.].